Why this is on people's radar
Glutathione is one of the most consequential small molecules in human biology. It's a tripeptide your cells make from glutamate, cysteine, and glycine. The active (reduced) form donates electrons to neutralize reactive oxygen species; the oxidized form is then recycled back to active form by glutathione reductase using NADPH. Glutathione is also a substrate for Phase II liver detoxification enzymes that conjugate toxins and drugs for excretion, and it modulates immune cell function. In short: it's a real, central, important molecule.
The wellness-clinic story is built on that biology. IV glutathione has become a longevity-and-wellness-clinic staple, sold for "detoxification," "anti-aging," "immune support," and (controversially in some markets) skin lightening. Sessions typically run $150 to $400 each. Oral glutathione exists too, but native glutathione has poor oral bioavailability, most of it gets broken down in the gut. Liposomal, acetylated, and S-acetyl glutathione formulations are intended to address that.
Outside the wellness world, glutathione has clinical research in Parkinson's disease (early trials suggesting modest benefit on motor symptoms), chemotherapy protection (where it's used in some oncology settings to reduce platinum-chemotherapy-induced neuropathy), and various oxidative-stress conditions. None of these uses have produced FDA approval of glutathione as a drug for those indications.
What people are usually trying to do with it
People reaching for glutathione (IV or oral) are usually trying to:
- "Detox", usually a vague concept that doesn't map well to actual liver biology
- Support antioxidant defense in the context of inflammatory or chronic conditions
- Get the perceived energy and skin-quality benefits associated with longevity-clinic IV menus
- Skin lightening / brightening (notably popular in some markets)
- Adjunctive support during chemotherapy or for Parkinson's disease (off-label clinical contexts)
- General "anti-aging" and oxidative-stress protocols
What the science actually shows
Plain-English summary:
Endogenous glutathione is essential
Well-established. Cells couldn't survive long without endogenous glutathione. Severe glutathione depletion is associated with significant cellular dysfunction.
Oral glutathione bioavailability is poor
Native glutathione is largely broken down by gut peptidases. Some studies suggest oral supplementation can raise glutathione status modestly with adequate dosing; the effect is much smaller than the supplement marketing implies. Liposomal forms have somewhat better bioavailability but still face the same fundamental challenges.
IV glutathione bioavailability is real but transient
IV administration produces transient elevations in plasma glutathione. Whether that translates into meaningful intracellular antioxidant benefit in healthy adults, the implied mechanism behind wellness-clinic use, is much less clear.
Parkinson's disease research
Small clinical trials of intranasal and IV glutathione in Parkinson's have suggested modest benefits on motor symptoms but haven't supported broader approval. Anyone with Parkinson's should be working with a neurologist using evidence-based options.
Chemotherapy protection (oncology context)
IV glutathione has been studied as adjunctive therapy to reduce platinum-chemotherapy-induced neuropathy. Use is at oncologist discretion in defined protocols. Anyone on chemotherapy should use only oncology-supervised supportive care.
What hasn't been demonstrated
FDA-approved indication for glutathione as a drug. Meaningful "anti-aging" benefit in healthy adults from IV or oral supplementation. The "detox" claims, in any specific clinical-meaningful sense.
The honest read
What's solid:
Endogenous glutathione is real, important biology. Oxidative stress is a real biological phenomenon. Specific clinical contexts (Parkinson's research, chemotherapy adjunctive support) have legitimate research behind them.
What's still being worked out:
Whether IV or oral glutathione meaningfully changes intracellular antioxidant status in healthy adults in ways that translate to clinical benefit. Whether liposomal and acetylated oral forms produce meaningfully different bioavailability than native oral.
What's hyped beyond the evidence:
"Detox" claims. The liver has a sophisticated detoxification system that doesn't really need outside support in healthy adults; "detox" as marketed by IV clinics doesn't map well to what actually happens at the cellular level. Wellness-clinic IV glutathione at $150-$400 per session for "anti-aging" rests on much thinner evidence than the price implies.
Things to know if you're looking into it
- Three main forms: IV (clinic-administered), oral native (poor bioavailability), liposomal/acetylated oral (somewhat better bioavailability).
- Cost varies: oral supplements $20-$60 per month; IV sessions $150-$400 each.
- "Detox" claims should be taken with skepticism: the liver's actual detox biology is well-characterized and generally functions without exogenous support in healthy adults.
- FDA status: sold as a dietary supplement (oral) or compounded preparation (IV). Not FDA-approved as a drug.
- Skin-lightening use is contested: popular in some markets but not approved for that purpose in the U.S. and the FDA has issued warnings about IV skin-lightening products generally.
- Healthcare provider involvement: appropriate for any clinical use case (Parkinson's, chemotherapy adjunct, etc.).
- Specific dosing protocols, mechanism, and the full reference list: all in the "Want to go deeper?" section below.
What people often ask
Does IV glutathione really work for anti-aging?
The biology is real; the wellness-clinic claims rest on much thinner evidence than the marketing implies. IV glutathione produces transient plasma elevations; whether that translates into meaningful clinical benefit in healthy adults isn't well-supported by trials.
What about oral glutathione?
Native oral glutathione has poor bioavailability, most gets broken down in the gut. Liposomal and acetylated forms have somewhat better bioavailability but the magnitude of effect on cellular glutathione status is modest. NAC (N-acetylcysteine, which provides cysteine for endogenous glutathione synthesis) is sometimes a more practical alternative.
Does it really detox the liver?
"Detox" as used in marketing doesn't map precisely to what your liver actually does. Glutathione is part of Phase II liver detoxification, but in healthy adults the system isn't overwhelmed and doesn't need exogenous support.
Is it safe?
Generally well-tolerated. Acute safety in IV and oral forms is favorable. The bigger concern is opportunity cost, paying premium prices for unclear benefit when established evidence-based interventions might be more useful.
Should I use it for Parkinson's or chemo neuropathy?
These are clinical contexts that should be managed by neurology and oncology specialists respectively. Some clinical use of glutathione exists in those settings; the right framing is "talk to your specialist" rather than "self-administer."
FDA and regulatory status
Status as of May 5, 2026: Sold as a dietary supplement (oral forms) or compounded preparation (IV). Not FDA-approved as a drug. The FDA has issued warnings against IV skin-lightening products generally. Status updates land here when they happen.
Want to go deeper?
Mechanism, the redox cycle, dosing, and references.
Background
Glutathione (γ-L-glutamyl-L-cysteinyl-glycine, GSH) is a tripeptide synthesized in cells from glutamate, cysteine, and glycine through the action of γ-glutamylcysteine synthetase and glutathione synthetase. Cysteine is typically the rate-limiting amino acid in synthesis.
Mechanism of action
The active (reduced) form donates an electron from its cysteine sulfhydryl group to neutralize reactive oxygen species, becoming the oxidized (GSSG) form. Glutathione reductase regenerates the reduced form using NADPH. Glutathione also conjugates with electrophilic toxins through Phase II glutathione-S-transferase enzymes for excretion. Modulates immune cell function and cellular signaling through redox-sensitive pathways.
Common dosing
Oral: 250-1000 mg daily as a supplement (variable bioavailability). IV (wellness-clinic): typically 600-2000 mg per session, weekly to biweekly.
References
- Lu SC. (2013). "Glutathione synthesis." Biochim Biophys Acta, 1830(5), 3143–3153. PubMed
- Richie JP, Nichenametla S, Neidig W, et al. (2015). "Randomized controlled trial of oral glutathione supplementation on body stores of glutathione." Eur J Nutr, 54(2), 251–263. PubMed
- Allen J, Bradley RD. (2011). "Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers." J Altern Complement Med, 17(9), 827–833. PubMed
- Mischley LK, Lau RC, Shankland EG, et al. (2017). "Phase IIb study of intranasal glutathione in Parkinson's disease." J Parkinsons Dis, 7(2), 289–299. PubMed
- Cascinu S, Catalano V, Cordella L, et al. (2002). "Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial." J Clin Oncol, 20(16), 3478–3483. PubMed